Regulation of SOX Proteins by Methylation-dependent Proteolysis in Stem Cells and Development

干细胞和发育中甲基化依赖性蛋白水解对 SOX 蛋白的调节

基本信息

  • 批准号:
    10308399
  • 负责人:
  • 金额:
    $ 30.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-12-01 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary The CRL4 ubiquitin ligase complexes regulate many important biological processes such as DNA replication, DNA repair, transcriptional regulation, and epigenetic inheritance of DNA methylation. We recently found that CRL4 also regulates the self-renewal and pluripotency of embryonic stem cells (ESCs) through important stem cell proteins such as SOX2 (SRY-box2). SOX2 is a dose-dependent master transcriptional factor that plays a key role in regulating the self-renewal and pluripotency or multipotency of ESCs, iPSCs, and many fetal and adult stem cells. In ESCs, an increase of SOX2 promotes development into ectoderm and mesoderm lineages, while loss or reduction of SOX2 induces differentiation into endoderm and trophectoderm lineages. Even at the 4-cell embryonic stage, the heterogeneous binding of SOX2 to target genes determines the first lineage decision. In human, loss-of-function mutations on a single Sox2 allele is sufficient to cause the familial anophthalmia/microphthalmia syndrome associated with seizures, brain abnormalities, slow growth, delayed motor skills and learning disability. Conversely, gene amplification and over-expression of SOX2 are frequently associated with many poorly differentiated cancers including lung, esophagus, brain, and breast cancers. However, it remains unclear how the SOX2 protein level is regulated in various stem/progenitor cells during development and tissue homeostasis. We recently found that the protein stability of SOX2 is regulated by a novel CRL4-based proteolytic mechanism using lysine methylation as a proteolytic trigger in ESCs and other related cells. Genetic mutation of this particular CRL4 function impairs embryonic development. We propose to unravel the function and regulation of this novel and important CRL4-based proteolytic mechanism in regulating self-renewal and pluripotency of ESCs and during embryonic development. Our specific aim 1 is to define the roles of CRL4-based ubiquitin E3 ligases that target the methylated SOX2 protein for degradation. Our specific aim 2 is to determine how the levels of methylated SOX2 proteins are dynamically regulated during the self-renewal of ESCs. In our specific aim 3, we propose to examine how the function of SOX2 is regulated in animal development using specific genetic mutants defective in the methylation- dependent proteolysis pathway. Since SOX2 is central to many stem cells and pathological loss or elevation of SOX2 levels underlies many diseases, our studies should reveal a novel paradigm by which the self-renewal and pluripotency or multipotency of various stem cells are regulated.
项目摘要 CRL 4泛素连接酶复合物调节许多重要的生物过程,如DNA 复制,DNA修复,转录调控和DNA甲基化的表观遗传。我们 最近发现,CRL 4还调节胚胎干细胞的自我更新和多能性 (ESCs)通过重要的干细胞蛋白如SOX 2(SRY-box 2)。SOX 2是一种剂量依赖性 在调节自我更新和多能性中起关键作用的主转录因子,或 干细胞是胚胎干细胞、诱导多能干细胞以及许多胎儿和成体干细胞的多能性。在ESC中,SOX 2的增加 促进发育成外胚层和中胚层谱系,而SOX 2的丢失或减少 诱导分化成内胚层和滋养外胚层谱系。即使在4细胞胚胎阶段, SOX 2与靶基因的异质结合决定了第一谱系决定。在人类中, 单个Sox 2等位基因上的功能缺失突变足以引起家族性 无眼/小眼综合征与癫痫发作、脑异常、生长缓慢, 运动技能延迟和学习障碍。相反,基因扩增和过度表达 SOX 2通常与许多低分化癌症相关,包括肺癌、食道癌、 脑癌和乳腺癌。然而,目前还不清楚SOX 2蛋白水平是如何调节的, 各种干/祖细胞在发展和组织稳态。我们最近发现, SOX 2的蛋白质稳定性由一种新的基于CRL 4的蛋白水解机制调节, 甲基化作为ESC和其他相关细胞中的蛋白水解触发剂。这种特殊的基因突变 CRL 4功能损害胚胎发育。我们建议解开的功能和调节 这种新的和重要的基于CRL 4的蛋白水解机制在调节自我更新和 胚胎干细胞的多能性和胚胎发育过程中。我们的具体目标1是确定 基于CRL 4的泛素E3连接酶,靶向甲基化SOX 2蛋白进行降解。我们的具体 目的2是确定甲基化SOX 2蛋白的水平如何动态调节, ESCs的自我更新。在我们的具体目标3中,我们建议检查SOX 2的功能是如何被激活的。 在动物发育中使用甲基化缺陷的特定遗传突变体进行调节- 依赖的蛋白水解途径。由于SOX 2是许多干细胞和病理性损失或 SOX 2水平的升高是许多疾病的基础,我们的研究应该揭示一个新的范式, 其调节各种干细胞的自我更新和多能性或多能性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HUI ZHANG其他文献

HUI ZHANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HUI ZHANG', 18)}}的其他基金

Synaptic Dysfunction and Energy Failure in Parkinson's Disease
帕金森病的突触功能障碍和能量衰竭
  • 批准号:
    10891269
  • 财政年份:
    2022
  • 资助金额:
    $ 30.96万
  • 项目类别:
Synaptic Dysfunction and Energy Failure in Parkinson's Disease
帕金森病的突触功能障碍和能量衰竭
  • 批准号:
    10504365
  • 财政年份:
    2022
  • 资助金额:
    $ 30.96万
  • 项目类别:
Regulation of SOX Proteins by Methylation-dependent Proteolysis in Stem Cells and Development
干细胞和发育中甲基化依赖性蛋白水解对 SOX 蛋白的调节
  • 批准号:
    10531566
  • 财政年份:
    2020
  • 资助金额:
    $ 30.96万
  • 项目类别:
Supplement: Regulation of SOX Proteins by Methylation-dependent Proteolysis in Stem Cells and Development
补充:干细胞和发育中甲基化依赖性蛋白水解作用对 SOX 蛋白的调节
  • 批准号:
    10810083
  • 财政年份:
    2020
  • 资助金额:
    $ 30.96万
  • 项目类别:
Elucidating Aberrant Dopamine Release in Schizophrenia
阐明精神分裂症中多巴胺的异常释放
  • 批准号:
    7871680
  • 财政年份:
    2010
  • 资助金额:
    $ 30.96万
  • 项目类别:
Elucidating Aberrant Dopamine Release in Schizophrenia
阐明精神分裂症中多巴胺的异常释放
  • 批准号:
    8055400
  • 财政年份:
    2010
  • 资助金额:
    $ 30.96万
  • 项目类别:
Regulation of Replication Checkpoint by Proteolysis
蛋白水解调节复制检查点
  • 批准号:
    7483524
  • 财政年份:
    2004
  • 资助金额:
    $ 30.96万
  • 项目类别:
Regulation of Replication Checkpoint by Proteolysis
蛋白水解调节复制检查点
  • 批准号:
    7066587
  • 财政年份:
    2004
  • 资助金额:
    $ 30.96万
  • 项目类别:
Regulation of Replication Checkpoint by Proteolysis
蛋白水解调节复制检查点
  • 批准号:
    6777947
  • 财政年份:
    2004
  • 资助金额:
    $ 30.96万
  • 项目类别:
Regulation of Replication Checkpoint by Proteolysis
蛋白水解调节复制检查点
  • 批准号:
    7236706
  • 财政年份:
    2004
  • 资助金额:
    $ 30.96万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 30.96万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了